Skip to main content

No increased suggestibility to placebo in functional neurological disorder

Huys, Anne-Catherine, Beck, Brianna, Haggard, Patrick, Bhatia, Kailash, Edwards, Mark (2021) No increased suggestibility to placebo in functional neurological disorder. European Journal of Neurology, . ISSN 1351-5101. (doi:10.1111/ene.14816) (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:87701)

PDF Author's Accepted Manuscript
Language: English

Restricted to Repository staff only until 9 March 2022.
Contact us about this Publication
[thumbnail of No increased suggestibility to placebo in FND_AAV.pdf]
XML Word Processing Document (DOCX) Author's Accepted Manuscript
Language: English

Restricted to Repository staff only
Contact us about this Publication
[thumbnail of No increased suggestibility to placebo in FND_AAV.docx]
Official URL
https://doi.org/10.1111/ene.14816

Abstract

Background and purpose: On the basis of occasional strong placebo responses, increased susceptibility to placebo has been proposed as a characteristic of functional neurological disorder (FND). The aim of this study was to clarify whether people with FND have a stronger placebo analgesic response than healthy controls. Methods: A study using a classic placebo paradigm, with additional conditioning and open‐label components, was performed in 30 patients with FND, and in 30 healthy controls. Ratings of mildly to moderately painful electrotactile stimuli were compared before and after the application of a placebo “anaesthetic” cream versus a control cream, after an additional conditioning exposure, and after full disclosure (open‐label component). Results: Pain intensity ratings at the placebo compared to the control site were similarly reduced in both groups. The conditioning exposure had no additional effect. After placebo disclosure a residual analgesic effect remained. Conclusion: Patients with FND did not have stronger placebo responses than healthy controls. The notion of generally increased suggestibility or increased suggestibility to placebo in FND seems mistaken. Instead, occasional dramatic placebo responses may occur because functional symptoms are inherently more changeable than those due to organic disease.

Item Type: Article
DOI/Identification number: 10.1111/ene.14816
Uncontrolled keywords: functional neurological disorder, conversion disorder, placebo, open‐label placebo, suggestibility, pain
Subjects: B Philosophy. Psychology. Religion > BF Psychology
R Medicine
Divisions: Divisions > Division of Human and Social Sciences > School of Psychology
Depositing User: Brianna Beck
Date Deposited: 21 Apr 2021 16:25 UTC
Last Modified: 22 Apr 2021 09:51 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/87701 (The current URI for this page, for reference purposes)
Huys, Anne-Catherine: https://orcid.org/0000-0003-3323-8077
Beck, Brianna: https://orcid.org/0000-0002-6784-6583
Haggard, Patrick: https://orcid.org/0000-0001-7798-793X
Bhatia, Kailash: https://orcid.org/0000-0001-8185-286X
Edwards, Mark: https://orcid.org/0000-0002-8283-9015
  • Depositors only (login required):